Stock 600062 CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company China Resources Double-Crane Pharmaceutical Co.,Ltd.

Equities

600062

CNE000000Q94

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
21.2 CNY -0.84% Intraday chart for China Resources Double-Crane Pharmaceutical Co.,Ltd. +0.66% +13.98%
Apr. 26 CR Double-Crane Pharmaceutical's Profit Rises 11% in Q1 as Revenue Grows 2% MT
Apr. 26 CR Double-Crane Pharmaceutical's Unit Gets Nod to Trial New Pain Medication MT

Business Summary

CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD. is a China-based company principally engaged in the development, manufacture and distribution of pharmaceuticals. The Company's main businesses are classified into three segments: Chronic Disease segment, Specialist segment and Infusion segment. Chronic Disease segment mainly provides products for lowering blood pressure, blood fat and blood glucose. Specialist segment mainly involves in the research, development and distribution of pharmaceuticals targeting six areas, including cardiovascular and cerebrovascular, pediatrics, kidney disease, mental/nerve, anesthesia and analgesia and respiratory areas. Infusion segment various types of infusion products, such as basic infusion, therapeutic infusion and nutritional. The Company distributes its products mainly in domestic market.

Sales per Business

CNY in Million2022Weight2023Weight Delta
Non-Transfusion
68.8 %
6,851 72.5 % 7,031 68.8 % +2.62%
Transfusion
32.4 %
2,688 28.5 % 3,312 32.4 % +23.20%
Inter-segment Eliminations
-1.2 %
-93 -1.0 % -121 -1.2 % +30.41%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
8,830 93.5 % 10,222 100.0 % +15.76%

Managers

Managers TitleAgeSince
Wen Chao Lu CHM
 Chairman - 23-09-20
Li Hong Zheng IRC
 Investor Relations Contact - -
Zhiyong Ge PRN
 Corporate Officer/Principal 61 06-06-01

Members of the board

Members of the board TitleAgeSince
Mao Zhu Sun BRD
 Director/Board Member 65 21-07-11
Ning Liu BRD
 Director/Board Member 66 06-05-29
Wei Zheng BRD
 Director/Board Member 64 18-06-21
Wen Chao Lu CHM
 Chairman - 23-09-20
Li Li Yan BRD
 Director/Board Member 50 16-09-18
Cai Lian Kang BRD
 Director/Board Member 50 18-06-21
Xiaosong Bai BRD
 Director/Board Member 53 22-03-01
Xiang ming Li BRD
 Director/Board Member 59 21-10-10
Zhan yi Yang BRD
 Director/Board Member 63 21-07-11
Shu Tian Yu BRD
 Director/Board Member 57 22-09-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,054,948,692 407,779,877 ( 38.65 %) 15,291,891 ( 1.450 %) 38.65 %

Shareholders

NameEquities%Valuation
CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED
61.09 %
625,795,624 61.09 % 1 790 M ¥
CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD.
2.165 %
22,176,409 2.165 % 63 M ¥
Da Cheng Fund Management Co., Ltd.
1.514 %
15,509,684 1.514 % 44 M ¥
GF Fund Management Co., Ltd.
1.502 %
15,391,684 1.502 % 44 M ¥
Citic Securities Co., Ltd. (Invt Port)
0.5649 %
5,787,504 0.5649 % 17 M ¥
Jian Zhong Yang
0.4715 %
4,830,000 0.4715 % 14 M ¥
China Southern Asset Management Co., Ltd.
0.4298 %
4,403,501 0.4298 % 13 M ¥
Huo Lin Chen
0.3111 %
3,187,000 0.3111 % 9 M ¥
China Merchants Fund Management Co., Ltd.
0.3084 %
3,158,960 0.3084 % 9 M ¥
Jian Guo Lin
0.2364 %
2,421,700 0.2364 % 7 M ¥
NameEquities%Valuation
Yan Xi Fan
1.343 %
250,900 1.343 % 717 556 ¥
Chao Man
1.333 %
248,900 1.333 % 711 837 ¥
Wen Chao Lu
1.272 %
237,600 1.272 % 679 519 ¥
Zi Qin Liu
0.9342 %
174,500 0.9342 % 499 058 ¥
Shuo Han
0.6746 %
126,000 0.6746 % 360 351 ¥

Holdings

NameEquities%Valuation
CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD.
2.16%
 22,176,409 2.16% 63,422,977 $

Company contact information

China Resources Double-Crane Pharmaceutical Co., Ltd.

1 Lize East 2nd Road Wangjing Subdistrict

100102, Beijing

+86 10 6474 2227

http://www.dcpc.com
address China Resources Double-Crane Pharmaceutical Co.,Ltd.(600062)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for China Resources Double-Crane Pharmaceutical Co.,Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
21.2 CNY
Average target price
24.91 CNY
Spread / Average Target
+17.52%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD. Stock China Resources Double-Crane Pharmaceutical Co.,Ltd.
+13.98% 2.99B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 600062 Stock
  4. Company China Resources Double-Crane Pharmaceutical Co.,Ltd.